Sight Sciences
SGHT
68 hedge funds and large institutions have $154M invested in Sight Sciences in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 15 reducing their positions, and 14 closing their positions.
87% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 15
0% more funds holding
Funds holding: 68 → 68 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 14
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
2.69% less ownership
Funds ownership: 53.32% → 50.63% (-2.7%)
33% less capital invested
Capital invested by funds: $228M → $154M (-$74.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$3.92M |
| 2 |
First Eagle Investment Management
New York
|
+$2.39M |
| 3 |
Millennium Management
New York
|
+$2.34M |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$2.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$9.82M |
| 2 |
SCM
Sio Capital Management
New York
|
-$6.52M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$4.64M |
| 4 |
Janus Henderson Group
London,
|
-$3.63M |
| 5 |
RI
RTW Investments
New York
|
-$2.81M |
SGHT Hedge Fund Activity: Q3 2022 in Review
68 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Sight Sciences (SGHT) for Q3 2022, worth a combined $154M — down 33% from $228M a quarter earlier.
Fund positioning in SGHT was balanced in Q3 2022: 14 funds opened new positions, 14 closed out, 28 added to existing stakes and 15 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $3.92M. The largest seller was JP Morgan Chase, cutting an estimated $9.82M.
- 68 institutional investors held Sight Sciences (SGHT) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $154M of Sight Sciences stock for Q3 2022, down 33% quarter-over-quarter.
- 14 funds opened new Sight Sciences positions in Q3 2022 and 14 closed out, a net change of 0 holders.
- The largest Sight Sciences buyer in Q3 2022 was Morgan Stanley, an estimated $3.92M added.
- The largest Sight Sciences seller in Q3 2022 was JP Morgan Chase, an estimated $9.82M sold.
Based on aggregated 13F filings for Q3 2022.